ARTICLE | Clinical News
Midostaurin regulatory update
October 4, 2004 7:00 AM UTC
EMEA granted Orphan Drug designation to NVS subsidiary Novartis Europharm Ltd. (West Sussex, U.K.) for midostaurin, a protein kinase C (PKC) inhibitor, to treat acute myeloid leukemia (AML). ...